Back
Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Ultragenyx Pharmaceutical Price Quote
$54.41
-0.02 (-1.43%)
(Updated: September 28, 2024 at 6:56 AM ET)
Ultragenyx Pharmaceutical Key Stats
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Day range:
$54.29 - $55.44
52-week range:
$31.52 - $60.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.15
P/B ratio:
11.6%
Volume:
575K
Avg. volume:
634.7K
1-year change:
47.47%
Market cap:
$5B
Revenue:
$434.2M
EPS:
$-7.3
How Much Does Ultragenyx Pharmaceutical Make?
-
How Much Are Ultragenyx Pharmaceutical's Sales Annually?
RARE Revenues are $434.2M -
How Much Profit Does Ultragenyx Pharmaceutical's Make A Year?
RARE net income is -$606.6M
Is Ultragenyx Pharmaceutical Growing As A Company?
-
What Is Ultragenyx Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.36% -
What Is Ultragenyx Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ultragenyx Pharmaceutical Stock Price Performance
-
Did Ultragenyx Pharmaceutical Stock Go Up Last Month?
Ultragenyx Pharmaceutical share price went down by -5.54% last month -
Did RARE's Share Price Rise Over The Last Year?
RARE share price rose by 47.47% over the past 1 year
What Is Ultragenyx Pharmaceutical 52-Week High & Low?
-
What Is Ultragenyx Pharmaceutical’s 52-Week High Share Price?
Ultragenyx Pharmaceutical has traded as high as $60.37 over the past 52 weeks -
What Is Ultragenyx Pharmaceutical’s 52-Week Low Share Price?
Ultragenyx Pharmaceutical has traded as low as $31.52 over the past 52 weeks
Ultragenyx Pharmaceutical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ultragenyx Pharmaceutical?
-
How Much Debt Does Ultragenyx Pharmaceutical Have?
Total long term debt quarterly is $0 -
How Much Cash Does Ultragenyx Pharmaceutical Have?
Cash and short term investments quarterly total is $763.8M -
What Is Ultragenyx Pharmaceutical’s Book Value Per Share?
Book value per share is 4.69
Is Ultragenyx Pharmaceutical Cash Flow Positive?
-
What Is RARE Cash Flow From Operations?
Cash flow from operations (TTM) is -$469.5M -
What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $740.7M -
What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is $112.3M
Ultragenyx Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
RARE return on invested capital is -290% -
What Is Ultragenyx Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is -42% -
What Is RARE Return On Equity?
ROE is a measure of profitability and is -290%
Ultragenyx Pharmaceutical Earnings Date & Stock Price
-
What Is Ultragenyx Pharmaceutical's Stock Price Today?
A single share of RARE can be purchased today for 54.43 -
What Is Ultragenyx Pharmaceutical’s Stock Symbol?
Ultragenyx Pharmaceutical trades on the nasdaq under the ticker symbol: RARE -
When Is Ultragenyx Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Ultragenyx Pharmaceutical is scheduled on November 1, 2024 -
When Is RARE's next ex-dividend date?
Ultragenyx Pharmaceutical's next ex-dividend date is May 27, 2020 -
How To Buy Ultragenyx Pharmaceutical Stock?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ultragenyx Pharmaceutical Competitors
-
Who Are Ultragenyx Pharmaceutical's Competitors?
Below is a list of companies who compete with Ultragenyx Pharmaceutical or are related in some way:
Ultragenyx Pharmaceutical Dividend Yield
-
What Is RARE Dividend Yield?
Ultragenyx Pharmaceutical’s dividend yield currently is 0% -
What Is Ultragenyx Pharmaceutical’s Payout Ratio?
Ultragenyx Pharmaceutical’s payout ratio is 0% -
When Did Ultragenyx Pharmaceutical Last Pay A Dividend?
The latest dividend pay date is September 28, 2024 -
What Is Ultragenyx Pharmaceutical’s Dividend Per Share?
Ultragenyx Pharmaceutical pays a dividend of $0.00 per share
Ultragenyx Pharmaceutical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 6.9% |
| Revenue: | 35.75% | 19.33% |
Analyst Recommendations
| Buy Recommendations: | 13 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 90.00 |
| Upside from Last Price: | 65.35% |